Opioid-based Versus Opioid-free Anaesthesia for Laparoscopic Cholecystectomy

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

October 15, 2024

Study Completion Date

October 31, 2024

Conditions
Surgical Procedure, UnspecifiedLaparoscopic Cholecystectomy
Interventions
DRUG

Dexmedetomidine injection

All the eligible patients will undergo general anaesthesia for their elective surgeries (Laparoscopic Cholecystectomies). For the induction and maintenance of anaesthesia the participants will be randomised in a 1:1 ratio to receive either a standard opioid-based anaesthesia (by Nalbuphine) or opioid-free anaesthesia (by Dexmedetomidine) treatment protocols.

DRUG

Nalbuphine Injection

All the eligible patients will undergo general anaesthesia for their elective surgeries (Laparoscopic Cholecystectomies). For the induction and maintenance of anaesthesia the participants will be randomised in a 1:1 ratio to receive either a standard opioid-based anaesthesia (by Nalbuphine) or opioid-free anaesthesia (by Dexmedetomidine) treatment protocols.

Trial Locations (1)

Unknown

Dow university hospital, Dow university of health sciences, Karachi

All Listed Sponsors
lead

Atif Shafqat

OTHER

NCT06476600 - Opioid-based Versus Opioid-free Anaesthesia for Laparoscopic Cholecystectomy | Biotech Hunter | Biotech Hunter